Results
1
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
1 companies
Cogstate
Market Cap: AU$301.4m
A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry-sponsored research.
CGS
AU$1.77
7D
2.0%
1Y
91.4%